Clinical Trials Directory

Trials / Completed

CompletedNCT02008747

Atrial Fibrillation and Neuropathic Pain After Thoracotomy and Continuous Application of Magnesium Sulphate.

Effects of Prophylactic Administration of Magnesium Sulfate on the Incidence of Atrial Fibrillation and Chronic Neuropathic Pain After Thoracotomy for Lung Resection.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Dr. Horst Schmidt Klinik GmbH · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Atrial fibrillation and chronic neuropathic pain are adverse events occurring after posterolateral thoracotomy for lung resection. The continuous application of magnesium sulphate may have a prophylactic effect. The investigators record the incidence of atrial fibrillation during a seven day period after thoracotomy as well as the incidence of chronic neuropathic pain during a three months period, comparing one group with a continuous application of magnesium sulphate against one group without magnesium sulphate.

Conditions

Interventions

TypeNameDescription
DRUGMagnesium sulphateContinuous application of magnesium sulphate applied 40 mg/kg ideal body weight by bolus before the operation started, followed by a continuous infusion of 10 mg/kg ideal body weight/h for 24 hours

Timeline

Start date
2011-01-01
Primary completion
2012-02-01
Completion
2012-05-01
First posted
2013-12-11
Last updated
2013-12-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02008747. Inclusion in this directory is not an endorsement.